FDA Inspection 1027039 — Grzegorz Kania, MD

Grzegorz Kania, MD — FEI 3013644403

The FDA completed an inspection of Grzegorz Kania, MD on September 29, 2017 in Skierniewice. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 29, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Skierniewice (Poland)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance